UPSTARNEWS
← 뉴스 목록
enUS

Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal Cancer Liver Metastases (CRCLM)

GlobeNewswire (all releases)· www.globenewswire.com
10/25/2026, 12:11 PM
1분 소요